ZA952409B - Sulfonamidocarbonylpyridine-2-carboxesteramides and their pyridine-N-oxides process for their preparation and their use as pharmaceuticals - Google Patents
Sulfonamidocarbonylpyridine-2-carboxesteramides and their pyridine-N-oxides process for their preparation and their use as pharmaceuticalsInfo
- Publication number
- ZA952409B ZA952409B ZA952409A ZA952409A ZA952409B ZA 952409 B ZA952409 B ZA 952409B ZA 952409 A ZA952409 A ZA 952409A ZA 952409 A ZA952409 A ZA 952409A ZA 952409 B ZA952409 B ZA 952409B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- bond
- opt
- sic
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4410480A DE4410480A1 (de) | 1994-03-25 | 1994-03-25 | Sulfonamidocarbonylpyridin-2-carbonsäureesteramide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA952409B true ZA952409B (en) | 1995-11-28 |
Family
ID=6513896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA952409A ZA952409B (en) | 1994-03-25 | 1995-03-24 | Sulfonamidocarbonylpyridine-2-carboxesteramides and their pyridine-N-oxides process for their preparation and their use as pharmaceuticals |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5620996A (cs) |
| EP (1) | EP0673932B1 (cs) |
| JP (1) | JPH07278110A (cs) |
| KR (1) | KR950032126A (cs) |
| AT (1) | ATE193702T1 (cs) |
| AU (1) | AU688450B2 (cs) |
| CA (1) | CA2145475A1 (cs) |
| CZ (1) | CZ289536B6 (cs) |
| DE (2) | DE4410480A1 (cs) |
| DK (1) | DK0673932T3 (cs) |
| ES (1) | ES2146676T3 (cs) |
| FI (1) | FI951387L (cs) |
| GR (1) | GR3033706T3 (cs) |
| HU (1) | HUT72598A (cs) |
| NO (1) | NO304265B1 (cs) |
| NZ (1) | NZ270784A (cs) |
| PL (1) | PL180678B1 (cs) |
| PT (1) | PT673932E (cs) |
| ZA (1) | ZA952409B (cs) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE256113T1 (de) * | 1996-03-21 | 2003-12-15 | Lonza Ag | Verfahren zur herstellung von arylamiden heteroaromatischer carbonsäuren |
| SK283920B6 (sk) | 1996-03-28 | 2004-05-04 | Lonza Ag | Spôsob výroby arylamidov heteroaromatických karboxylových kyselín |
| SI0806415T1 (en) * | 1996-05-09 | 2000-04-30 | Lonza Ag | Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| US6169183B1 (en) | 1996-07-23 | 2001-01-02 | Lonza, Ltd. | Process for preparing pyridinecarboxylic esters |
| CA2209392C (en) * | 1996-07-23 | 2007-02-20 | Yves Bessard | Process for preparing pyridinecarboxylic esters |
| DE19742951A1 (de) * | 1997-09-29 | 1999-04-15 | Hoechst Schering Agrevo Gmbh | Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung |
| CN102552263A (zh) | 2001-12-06 | 2012-07-11 | 法布罗根股份有限公司 | 提高内源性红细胞生成素(epo)的方法 |
| EP2295060B1 (en) | 2001-12-06 | 2018-10-31 | Fibrogen, Inc. | Treatment or prevention of ischemic or hypoxic conditions |
| US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US7618940B2 (en) * | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
| US8614204B2 (en) * | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| EP1491527A1 (en) * | 2003-06-25 | 2004-12-29 | Bayer CropScience GmbH | Process for preparing acylsulfamoylbenzamides |
| CN101242817B (zh) | 2005-06-15 | 2016-08-31 | 菲布罗根公司 | HIF1α调节剂在治疗癌症中的用途 |
| WO2007114612A1 (en) * | 2006-03-30 | 2007-10-11 | Lg Electronics Inc. | A method and apparatus for decoding/encoding a video signal |
| AU2007265460B2 (en) | 2006-06-26 | 2011-03-03 | Akebia Therapeutics Inc. | Prolyl hydroxylase inhibitors and methods of use |
| US8962530B2 (en) * | 2007-06-27 | 2015-02-24 | Regents Of The University Of Colorado | Inflammatory bowel disease therapies |
| NO2686520T3 (cs) | 2011-06-06 | 2018-03-17 | ||
| NZ714963A (en) | 2013-06-13 | 2020-07-31 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
| MA39033A1 (fr) | 2013-11-15 | 2017-11-30 | Akebia Therapeutics Inc | Formes solides d'acide {[5-(3-chlorophényl)-3-hydroxypyridine-2-carbonyl] amino}acétique, compositions et leurs utilisations |
| HK1247201A1 (zh) | 2015-01-23 | 2018-09-21 | 阿克比治疗有限公司 | 2-(5-(3-氟苯基)-3-羥基吡啶甲醯胺)乙酸的固體形式、其組合物及用途 |
| TWI718138B (zh) | 2015-04-01 | 2021-02-11 | 美商阿克比治療有限公司 | 用於治療貧血之組合物及方法 |
| CN105130888A (zh) * | 2015-10-09 | 2015-12-09 | 中国药科大学 | 炔基吡啶类脯氨酰羟化酶抑制剂、其制备方法和医药用途 |
| TWI822776B (zh) | 2018-05-09 | 2023-11-21 | 美商阿克比治療有限公司 | 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法 |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0541042A1 (de) * | 1991-11-05 | 1993-05-12 | Hoechst Aktiengesellschaft | Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
| TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-03-25 DE DE4410480A patent/DE4410480A1/de not_active Withdrawn
-
1995
- 1995-03-13 DE DE59508440T patent/DE59508440D1/de not_active Expired - Fee Related
- 1995-03-13 PT PT95103582T patent/PT673932E/pt unknown
- 1995-03-13 AT AT95103582T patent/ATE193702T1/de not_active IP Right Cessation
- 1995-03-13 DK DK95103582T patent/DK0673932T3/da active
- 1995-03-13 ES ES95103582T patent/ES2146676T3/es not_active Expired - Lifetime
- 1995-03-13 EP EP95103582A patent/EP0673932B1/de not_active Expired - Lifetime
- 1995-03-23 NZ NZ270784A patent/NZ270784A/en unknown
- 1995-03-23 AU AU15043/95A patent/AU688450B2/en not_active Ceased
- 1995-03-23 FI FI951387A patent/FI951387L/fi unknown
- 1995-03-23 CZ CZ1995734A patent/CZ289536B6/cs not_active IP Right Cessation
- 1995-03-24 PL PL95307847A patent/PL180678B1/pl unknown
- 1995-03-24 CA CA002145475A patent/CA2145475A1/en not_active Abandoned
- 1995-03-24 JP JP7065926A patent/JPH07278110A/ja active Pending
- 1995-03-24 US US08/410,610 patent/US5620996A/en not_active Expired - Fee Related
- 1995-03-24 NO NO951149A patent/NO304265B1/no not_active IP Right Cessation
- 1995-03-24 ZA ZA952409A patent/ZA952409B/xx unknown
- 1995-03-24 HU HU9500864A patent/HUT72598A/hu unknown
- 1995-03-25 KR KR1019950006805A patent/KR950032126A/ko not_active Ceased
-
2000
- 2000-06-16 GR GR20000401396T patent/GR3033706T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO951149D0 (no) | 1995-03-24 |
| KR950032126A (ko) | 1995-12-20 |
| AU688450B2 (en) | 1998-03-12 |
| DK0673932T3 (da) | 2000-09-18 |
| DE59508440D1 (de) | 2000-07-13 |
| HK1011973A1 (en) | 1999-07-23 |
| ATE193702T1 (de) | 2000-06-15 |
| AU1504395A (en) | 1995-10-05 |
| NO304265B1 (no) | 1998-11-23 |
| EP0673932A1 (de) | 1995-09-27 |
| DE4410480A1 (de) | 1995-09-28 |
| NZ270784A (en) | 1997-02-24 |
| HUT72598A (en) | 1996-05-28 |
| NO951149L (no) | 1995-09-26 |
| CZ73495A3 (en) | 1995-11-15 |
| CA2145475A1 (en) | 1995-09-26 |
| PL307847A1 (en) | 1995-10-02 |
| FI951387A7 (fi) | 1995-09-26 |
| GR3033706T3 (en) | 2000-10-31 |
| EP0673932B1 (de) | 2000-06-07 |
| PL180678B1 (pl) | 2001-03-30 |
| FI951387A0 (fi) | 1995-03-23 |
| PT673932E (pt) | 2000-09-29 |
| JPH07278110A (ja) | 1995-10-24 |
| US5620996A (en) | 1997-04-15 |
| ES2146676T3 (es) | 2000-08-16 |
| FI951387L (fi) | 1995-09-26 |
| CZ289536B6 (cs) | 2002-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA952409B (en) | Sulfonamidocarbonylpyridine-2-carboxesteramides and their pyridine-N-oxides process for their preparation and their use as pharmaceuticals | |
| FI951386A0 (fi) | Sulfanamidokarbonyylipyridiini-2-karboksyylihappoamidit sekä niiden pyridiini-N-oksidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| ES2117901T3 (es) | Nuevos derivados siliciados del acido salicilico con propiedades descamantes. | |
| GR3034620T3 (en) | Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL109397A0 (en) | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT49349A (en) | Process for producing substituted 6-phenyldihydro-3-/2h/-pyridazinone derivatives and pharmaceutical compositions comprising such compounds | |
| HU9503005D0 (en) | Quinoxaline derivatives, process for producing them and use of them | |
| HU9802645D0 (en) | New metalloproteinase inhibitors, process for producing them, and pharmaceutical compositions containing them | |
| HUT45255A (en) | Process for producing furo/3,4-b/pyridine derivatives and pharmaceutical compositions comprising these compounds | |
| GR3035644T3 (en) | Aminated 6,7,8,9-tetrahydro-cyclopenta[a]naphtalene- and 2,3-dihydro-cyclopenta[e]indene-derivatives, process for their preparation and pharmaceutical compsitions containing them | |
| IL115028A0 (en) | Cyclohexadiene derivatives their pharmaceutical compositions containing them | |
| HUT50469A (en) | Process for producing quinolinecarboxylic acids substituted by heterocyclic group | |
| HUT48893A (en) | Process for producing new cepheme derivatives | |
| HUT60742A (en) | Method for producing imidqzo-benzodiazepine-2-(1h)-one derivatives and pharmaceutical preparatives containing them |